SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-032097
Filing Date
2017-08-14
Accepted
2017-08-14 17:02:32
Documents
44
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 416201
2 EXHIBIT 31 ex31.htm EX-31 13455
3 EXHIBIT 32 ex32.htm EX-32 5857
  Complete submission text file 0001140361-17-032097.txt   2955953

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ocx-20170630.xml EX-101.INS 420301
5 XBRL TAXONOMY EXTENSION SCHEMA ocx-20170630.xsd EX-101.SCH 33047
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ocx-20170630_cal.xml EX-101.CAL 38526
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ocx-20170630_def.xml EX-101.DEF 133916
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocx-20170630_lab.xml EX-101.LAB 474696
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocx-20170630_pre.xml EX-101.PRE 248946
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 171031359
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences